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Abstract
Rationale: Under some conditions stress, rather than directly triggering
cocaine seeking, potentiates reinstatement to other stimuli, including a subthreshold cocaine dose. The mechanisms responsible for stress-potentiated
reinstatement are not well-defined. Endocannabinoid signaling is increased by
stress and regulates synaptic transmission in brain regions implicated in
motivated behavior.
Objectives: To test the hypothesis that cannabinoid receptor 1 (CB1R)
signaling is required for stress-potentiated reinstatement of cocaine seeking
in rats.
Methods: Following i.v. cocaine self-administration (2 hr access/day) and
extinction in male rats, footshock stress alone does not reinstate cocaine
seeking, but reinstatement is observed when footshock is followed by an
injection of an otherwise subthreshold dose of cocaine (2.5 mg/kg, i.p.).
CB1R involvement was tested by systemic administration of the CB1R
antagonist AM251 (0, 1, or 3 mg/kg, i.p.) prior to testing for stresspotentiated reinstatement.
Results: Stress-potentiated reinstatement was blocked by both 1 and 3
mg/kg AM251. By contrast, AM251 only attenuated food-reinforced lever
pressing at the higher (i.e., 3 mg/kg) dose and did not affect locomotor
activity at either dose tested. Neither high-dose cocaine-primed reinstatement
(10 mg/kg, i.p.) nor footshock stress-triggered reinstatement following longaccess cocaine self-administration (6 hr access/day) were affected by AM251
pretreatment. Footshock stress increased concentrations of both
endocannabinoids, N-arachidonylethanolamine and 2-arachidonoylglycerol, in
regions of the prefrontal cortex.
Conclusions: These findings demonstrate that footshock stress increases
prefrontal cortical endocannabinoids and stress-potentiated reinstatement is
CB1R-dependent, suggesting that CB1R is a potential therapeutic target for
relapse prevention, particularly in individuals whose cocaine use is stressrelated.
Keywords: addiction, cocaine, stress, reinstatement, relapse,
endocannabinoid, self-administration
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Introduction
The sudden and often unpredictable relapse to drug use that can
emerge even after prolonged periods of drug abstinence is a major
obstacle to the effective long-term management of substance abuse.
The ability to prevent relapse has been hindered by an imprecise and
incomplete understanding of situations that lead to the re-emergence
of drug-seeking behavior and the underlying neurobiological
processes.
Stress plays a particularly problematic role in drug relapse
(McReynolds et al. 2014; Shaham et al. 2000) as it is prevalent and
unavoidable in daily life. While it is evident that stress contributes to
relapse, the manner in which it does so appears to be more complex
than simply triggering use. For example, while clinical laboratory
studies have found that stress imagery can trigger craving (Sinha
2009), self-reports by addicts regarding the role of stress in their drug
use are suggestive of a less direct relationship between stress and
relapse (Furnari et al. 2015; Preston and Epstein 2011). Consistent
with this more nuanced role for stress, others have reported that
stress may interact with other relapse triggers to promote drug use
(Coffey et al. 2002; De La Garza et al. 2009; Duncan et al. 2007).
These reports parallel findings from preclinical studies showing that
acute stressors can potentiate reinstatement induced by cocainerelated cues in rats (Buffalari and See 2009; Feltenstein and See
2006).
Previous studies from our laboratory have demonstrated that
the ability of intermittent electric footshock to reinstate extinguished
cocaine seeking in rats can vary depending on the prior history of
cocaine use. We have identified conditions under which rats with a
history of extended access cocaine self-administration (14 × 6
hrs/day) show robust footshock-triggered reinstatement of cocaine
seeking following extinction, while rats that have a history of more
limited daily access (14 × 2 hrs/day) do not (Mantsch et al. 2008a).
However, although footshock stress does not directly reinstate cocaine
seeking following self-administration under these short-access
conditions, it can amplify the effects of an otherwise sub-threshold
priming injection of cocaine (2.5 mg/kg; Graf et al. 2013), thereby
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potentiating reinstatement. We have proposed that this potentiating
effect of footshock stress reflects its role in many drug users in whom
stress appears to “set the stage” for cocaine use. In contrast to the
relapse-triggering effects of stress, which have been extensively
studied, relatively little is known about the neurobiological
mechanisms that underlie these stage-setting effects of stress.
We recently reported that stress-potentiated reinstatement,
unlike stress-triggered reinstatement (Mantsch et al. 2008a), is
corticosterone-dependent, and that elevated corticosterone is sufficient
to reproduce the potentiating effect of stress (Graf et al. 2013).
Moreover, we found that one corticosterone-dependent mechanism
through which stress potentiates cocaine-induced reinstatement
involves reduced dopamine clearance in the nucleus accumbens by the
glucocorticoid-sensitive organic cation transporter 3 (OCT3; Graf et al.
2013). Endocannabinoid (eCB) signaling represents a second
corticosterone-dependent mechanism through which stress could
potentiate cocaine-induced reinstatement. Both stress and
corticosterone increase eCB levels in brain regions that have been
implicated in drug-seeking behavior, most notably the prefrontal
cortex (PFC) and nucleus accumbens (NAc; Hill et al. 2011;
Rademacher et al. 2008). In the brain, the CB1Rs are thought to
represent the primary targets for eCB signaling (Devane et al. 1988;
Egertova et al. 1998; Herkenham et al. 1991; Howlett et al. 2002;
Pertwee 1997; Pertwee and Ross 2002), although CB2R-mediated
effects have been reported (Brusco et al. 2008; Onaivi 2011; Onaivi et
al. 2006). As CB1Rs have been proposed to play a critical role in both
drug addiction (Sidhpura and Parsons 2011) and adaptation to stress
(Hill et al. 2010), we hypothesize that stress potentiation of cocaineinduced reinstatement requires eCB signaling through CB1Rs. In the
present study we test this hypothesis by assessing the effects of the
CB1R antagonist, AM251, on stress-potentiated reinstatement.

Methods
Subjects
Male Sprague-Dawley rats (275–300 g at arrival), obtained from
Harlan Laboratories, were individually housed in a humidity- and
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temperature-controlled AAALAC-accredited facility with food and water
available ad libitum. Rats were maintained on a 12h/12h reverse
light/dark cycle (0700–1900 lights off) and all behavioral procedures
were conducted during the dark phase of the light cycle. All
experimental procedures were carried out in compliance with National
Institutes of Health guidelines and were approved by the Institutional
Animal Care and Use Committee (Marquette University).

Catheter implantation
For intravenous self–administration and reinstatement testing,
each rat was anesthetized with ketamine HCl (100 mg/kg, i.p.) and
xylazine (2 mg/kg, i.p.) and had an indwelling silicon (Silastic; Dow
Corning; 0.64 mm i.d.; 1.19 mm o.d.) catheter implanted into the
jugular vein. Catheters were connected to back mount cannulae
(Plastics One) attached to monofilament surgical mesh (Atrium
Medical). When placed in the operant chambers, the back mount
cannulae was connected to PE tubing (0.51 mm i.d. × 1.52 mm o.d.)
encased in stainless-steel spring leashes (Plastics One). The PE tubing
was connected via a fluid swivel (Instech Lab) suspended above the
self–administration chamber and Tygon tubing (VWR; 0.51 mm i.d. ×
1.52 mm o.d.) to syringes in pumps (Razel) outside of the operant
chamber. Rats received ibuprofen in their drinking water for 3 days
following surgery and were given iv antibiotic treatment for at least 5
days. The rats were allowed to recover for 1 week before the initiation
of self–administration training.

Cocaine Self-Administration
Self-administration/reinstatement procedures were conducted in
computer-interfaced operant conditioning chambers equipped with
retractable levers and stimulus lights above each lever in soundattenuating cubicles (MED-Associates). Following recovery from
surgery, rats were trained to self-administer cocaine (0.5
mg/kg/infusion) by pressing a lever under a fixed-ratio (FR) 1
schedule during daily 2-h sessions. Pressing the lever resulted in an
infusion (200 μL over 5 s) followed by a 10 s time-out period during
which lever presses were recorded but not reinforced and the stimulus
light above the lever was extinguished. Responding on a second lever,
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the inactive lever, was also recorded, but not reinforced. Following
stable responding, the FR value was increased gradually to FR4. Once
stable responding on FR4 was achieved (<10% change over 3 days),
rats were allowed to self-administer cocaine daily for 14 additional
days.

Extinction and reinstatement
After 14 days of cocaine self-administration, rats underwent
extinction training which was identical to cocaine self-administration
with the exception that the cocaine was replaced with saline. Rats
underwent daily 2-h extinction training sessions until they met the
extinction criterion (<15 lever presses/2 h). Once rats met this
criterion, a reinstatement test was given the next day. Aside from
footshock and/or cocaine pre-exposure, reinstatement sessions were
otherwise identical to extinction conditions. All rats underwent multiple
reinstatement tests within each experiment in a counterbalanced
fashion. Each rat received a maximum of 4 reinstatement tests. Rats
were given additional extinction/washout sessions between
reinstatement tests until they reached criterion (<15 lever presses/2
h) before receiving additional reinstatement tests.

Experiment 1: Effect of CB1R antagonism on stresspotentiated reinstatement of cocaine seeking
Under the self–administration parameters used in the present
study (0.5 mg/kg/inf; 14 × 2 hrs/day), we have found previously that
footshock alone does not trigger reinstatement of extinguished cocaine
seeking, but potentiates reinstatement in response to an injection of
an otherwise subthreshold dose of cocaine (2.5 mg/kg, i.p.; Graf et al.
2013). Following self-administration and extinction, all rats were
tested for reinstatement under each of the following conditions, in
counter-balanced sequence: 1) no footshock/cocaine; 2)
footshock/saline; and 3) footshock/cocaine following 30-min
pretreatment with the CB1R antagonist, AM251 (1 or 3 mg/kg, i.p.), or
vehicle (1:1:18 ethanol: Cremaphor: saline). Separate sets of rats
were used for each dose of AM251 so each rat received 4
reinstatement tests total. Intermittent electric footshock (3 × 0.5 mA,
200 ms duration, mean intershock interval 40s, range 10–70s over a
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15 min period) was delivered through the stainless-steel grid floors of
the operant conditioning chambers immediately prior to cocaine (2.5
mg/kg, i.p.) or saline (0.9% NaCl) injections followed by the 2-h
reinstatement test sessions.

Experiment 2: Effect of CB1R antagonism on cocaineprimed and stress-triggered reinstatement of cocaine
seeking
We have previously reported that stress-potentiated
reinstatement is mediated in part by a mechanism that is distinct from
that involved in either stress-triggered or cocaine-primed
reinstatement; stress-potentiated reinstatement is corticosteronedependent (Graf et al. 2013), while stress-triggered and cocaineprimed reinstatement are not (Erb et al. 1998; Graf et al. 2011;
Mantsch et al., 2008b). To determine if CB1R involvement is also
selective for stress-potentiated cocaine seeking, we tested separate
groups of rats for the effects of AM251 on cocaine-primed and stresstriggered reinstatement.
To test for the effect of AM251 on cocaine-primed
reinstatement, rats underwent cocaine self-administration and
extinction as described above, but were given a systemic injection of a
dose of cocaine (10 mg/kg, i.p) which has been reported to reliably
reinstate cocaine seeking (Mantsch et al. 2008b; Mantsch and Goeders
1999; Mantsch et al. 2004), or saline immediately prior to the start of
the 2-h reinstatement session. As above, rats were pretreated with
AM251 (1, 3 mg/kg, ip) or vehicle (1:1:18 ethanol: Cremaphor:
saline) 30 min prior to the start of the reinstatement test. Each rat
was tested for reinstatement under each of the following conditions in
counterbalanced condition: 1) vehicle/saline; 2) vehicle/cocaine; 3)
AM251/cocaine. Rats were given extinction/washout sessions between
reinstatement tests until they reached criterion (<15 lever presses/2
h) before receiving additional reinstatement tests. Each rat received all
reinstatement tests in a counterbalanced order and received a total of
3 reinstatement tests.
To determine if CB1R activation represents a distinct mechanism
that underlies the ability of stress to potentiate, rather than directly
trigger induce reinstatement, we tested a separate group of rats for
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the effect of AM251 under conditions in which footshock stress alone
can trigger reinstatement of extinguished cocaine seeking. We have
previously shown that delivery of footshock alone produces reliable
and robust reinstatement of cocaine seeking in rats with a history of
longer daily access to cocaine self-administration (6 hrs/day; Mantsch
et al. 2008a; Blacktop et al. 2011; Vranjkovic et al. 2014). In these
experiments, rats were provided with daily long access (6 hr/day × 14
days) to cocaine (0.5 mg/kg/inf) for self-administration prior to
extinction (as described above) and testing for footshock stresstriggered reinstatement (same footshock conditions as above). To test
for CB1R involvement in stress-triggered reinstatement, rats were
pretreated with either AM251 (1 mg/kg, ip) or vehicle (1:1:18 ethanol:
Cremaphor: saline) 30 min prior to delivery of footshock followed by
reinstatement testing. Each rat was tested under the following
reinstatement conditions, in a counterbalanced order: 1) vehicle/no
footshock; 2) vehicle/footshock; 3) AM251/no footshock; 4)
AM251/footshock. Rats were given extinction/washout sessions
between reinstatement tests until they reached criterion (<15 lever
presses/2 h) before receiving additional reinstatement tests. Each rat
received a total of 4 reinstatement tests and was required to once
again meet the extinction criterion (<15 lever presses/2h) between
tests.

Experiment 3: Effect of CB1R antagonism on responding
for food and basal locomotor activity
Although the lack of AM251 effects on cocaine-primed and
stress-triggered reinstatement suggests that the effects of the drug on
stress-potentiated reinstatement were not secondary to non-specific
motor suppression, we decided to further address this possibility by
testing a separate group of rats for AM251 effects on food-reinforced
responding and locomotor activity. When testing for effects on foodreinforced behavior, rats were food deprived to 90% of their starting
body weight and trained to press a lever under a FR4 schedule of
sucrose-sweetened food pellet (45 mg; BioServ) reinforcement during
daily 30-min sessions. Drug effects were tested once stable responding
was achieved (<10% change over 3 days). AM251 (1, 3 mg/kg, ip) or
vehicle (1:1:18 ethanol: Cremaphor: saline) was administered 30 min
prior to the start of the session. Each rat received vehicle and both
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doses of AM251 in a counterbalanced order for a total of 3 tests. Rats
were given additional days between drug tests to ensure that stable
food responding was once again achieved before the next test.
As there is strong evidence for a role of endocannabinoids in
feeding, metabolism, and obesity (Bellocchio et al. 2006; Kirkham and
Tucci 2006; Silvestri and Di Marzo 2013), food responding alone may
not be the most accurate measurement of CB1R antagonist effects on
motor activity. Therefore, the effect of AM251 on basal locomotor
behavior was also determined. Locomotor activity was measured in the
home cages of the rats using an automated activity system (AccuScan
Instruments, Inc., Columbus, OH) consisting of photocell-containing
frames, equipped with sensor panels containing 16 photo beams in a
horizontal orientation, into which cages could be placed for recording.
Both total (total photobeam breaks) and ambulatory (consecutive
photobeam) breaks activity counts were recorded using a computer
interfaced MicroMax software-based system (AccuScan Instruments).
Prior to testing for drug effects, rats received 3 days of systemic i.p.
saline injections to habituate them to injections and limit the
contribution of novelty/injection stress-related effects. Thereafter, all
rats were tested for effects of AM251 (1 and 3 mg/kg, ip) and vehicle
(1:1:18 ethanol: Cremaphor: saline) in a counterbalanced sequence
with washout days between each test. Locomotor activity was
recorded for one hour starting immediately post-injection.

Experiment 4: Effect of footshock stress on
endocannabinoid content in the medial prefrontal cortex
The medial prefrontal cortex (mPFC) is critical for cocaine
seeking in response to multiple reinstating stimuli, including footshock
and cocaine (McFarland et al. 2004). Subregions of the mPFC (e.g.,
prelimbic, infralimbic cortices, anterior cingulate) appear to have
differential roles in reinstatement following exposure to stress
(Capriles et al. 2003) or cocaine (Capriles et al. 2003; Peters et al.
2008). While it has been reported that stress can increase
endocannabinoid content in the mPFC (Hill et al. 2011), most studies
examining the effect of stress on eCB content have utilized acute
restraint or forced swim as stressors (Hill et al. 2011; McLaughlin et al.
2012; Rademacher et al. 2008; Roberts et al. 2012). We conducted a
preliminary analysis of the effects of footshock stress on eCB content
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in subregions of the mPFC in rats with no history of cocaine selfadministration. Rats were handled for 2 min/day for 3 days prior to
exposure to the footshock. On the day of testing, rats were
transported to the experimental room 1-h prior to administration of
footshock stress. Rats were placed into the operant conditioning
chambers and received the same 15-min footshock stress that was
administered during reinstatement testing: control rats were placed in
the operant chambers for 15 min but did not receive the stressor.
Immediately after the 15-min footshock session, rats were placed back
into their home cages and 15 min later were rapidly decapitated under
isoflurane anesthesia (30-s exposure) for tissue collection. Brains were
rapidly removed (2.5 min total time) and flash frozen by submersion in
liquid nitrogen for 25s and then stored at −80°C.
For tissue dissection, 1 mm prefrontal cortical sections (approx.
3.72 mm to −2.76 mm from Bregma) were isolated from coronal
sections on dry ice. Prefrontal cortical subregions (prelimbic (PL),
infralimbic (IL), and anterior cingulate cortices (AC)) were dissected
bilaterally using a scalpel blade, weighed and collected in a
microcentrifuge tube and stored at −80°C. Subregions from two
animals were pooled for each data point.

Endocannabinoid Liquid Chromatography/Mass
Spectrometry
Concentrations of the endocannabinoids Narachidonylethanolamine (AEA) and 2-arachidonylglycerol (2-AG) were
extracted from tissue using a protocol adapted from Patel et al. 2003.
Briefly, tissue samples were homogenized in 2mL of acetonitrile with
84 pmol [2H8]AEA and 186pmol [2H8]2-AG using glass rods. Samples
were sonicated for 60 min and frozen overnight at −20°C to
precipitate proteins. The supernatant was obtained following
centrifugation at 1500 × g for 2 min at 4°C, was dried under N2 and
the lipids were resuspended in methanol. The two endocannabinoids
were isolated and quantified by liquid chromatography-electrospray
ionization-mass spectrometry (LC-ESI-MS; Agilent LC-MSD 1100
series) and quantified by isotope dilution as described previously (Patel
et al. 2003).
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Drugs
Cocaine HCl was obtained from the National Institute on Drug
Abuse (NIDA) through the NIDA Drug Supply Program. The CB1R
antagonist AM251 was purchased from Sigma-Aldrich. Cocaine was
dissolved in saline (0.9% bacteriostatic saline). AM251 was dissolved
first in ethanol, followed by Cremaphor and finally by saline (0.9%
bacteriostatic saline) in a 1:1:18 ratio.

Statistical Analysis
Statistical analyses were conducted using SPSS statistics
software and consisted of one- or two-way repeated measures ANOVA
followed, when appropriate, with post-hoc testing using Bonferronicorrected t-tests. For all analyses, statistical significance was defined
as p<0.05.

Results
The numbers of cocaine infusions and responses during the selfadministration and extinction sessions for each reinstatement
experiment are shown in Table 1. Rats showed consistent responding
during self-administration between self–administration day 1 and 14 in
experiments 1 and 2. Following completion of cocaine selfadministration, rats showed a reduction in lever presses across
extinction sessions in both experiments and took an average of 7.67 ±
1.38 extinction sessions before reaching criteria.
Table 1. Cocaine self-administration and extinction responding
Experiment no. (n) Cocaine SA
SA Day 1

Extinction
SA Day 14

1 ShA; (12)

121.4 ± 7.5 126.8 ± 7.8

2 ShA; (8)

117.3 ± 10.6 120.0 ± 11.0

First Ext Last Ext
75.9 ± 7.2 9.9 ± 1.0
77.4 ± 19.3 9.1 ± 1.8

LgA; (5)
317.8 ± 34.2 396.0 ± 12.54 166.8 ± 41.2 7.6 ± 2.6
Data represent total active lever responses/2-h session ± SEM for experiments 1 and
2 for short access (ShA) experiments, and lever responses/6-hr session ± SEM for
experiment 2 for long-access (LgA) experiments during days 1 and 14 of cocaine selfadministration (SA) and total active lever responses/2-h session ± SEM on the first
day of extinction (Ext) and the last day of extinction before reinstatement testing for
experiments 1 and 2.
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Experiment 1: Effect of CB1R antagonism on
stress-potentiated reinstatement of cocaine
seeking
To confirm that stress produced a potentiation of cocaineinduced reinstatement, as previously described (Graf et al. 2013) we
initially compared reinstatement following administration of the
footshock/cocaine combination with reinstatement following
footshock/saline or administration of cocaine alone (no
footshock/cocaine) only in rats pretreated with the vehicle for AM251
(1:1:18 ethanol: Cremaphor: saline). As previously reported in rats
tested under the same self-administration conditions (Graf et al.
2013), neither low-dose cocaine (2.5 mg/kg, i.p.) nor footshock alone
reinstated cocaine seeking. However, robust reinstatement was
observed when the two stimuli were combined (Fig. 1). A two-way
repeated measures ANOVA showed significant main effects of
reinstatement testing (extinction vs. reinstatement; F(1,22)=45.26,
p<0.001) and reinstatement condition (footshock/saline, no
footshock/cocaine, footshock/cocaine; F(2,22)=24.42, p<0.001) and a
significant interaction between the reinstatement day and
reinstatement condition (F(2,22)=25.52, p<0.001). Post-hoc testing
revealed significant reinstatement (compared to extinction responses)
following delivery of the footshock/cocaine combination (p<0.001) but
not with footshock/saline or cocaine alone. Moreover, while no
differences in extinction responding were observed across treatment
conditions, responding during the reinstatement session that followed
delivery of the footshock/cocaine was increased compared to
responding following footshock/saline or cocaine alone (p<0.001).
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Figure 1. Stress-potentiated reinstatement is CB1R-dependent. Data represent mean
active lever responses (± SEM) during 2-h extinction and reinstatement tests. Stresspotentiated reinstatement is observed when rats are exposed to a stressor, 15 min
intermittent electric footshock stress (EFS) followed immediately by a subthreshold
dose of cocaine (COC, 2.5 mg/kg, i.p.; **p<.01, compared to reinstatement). Stresspotentiated reinstatement is blocked by pre-treatment with the CB1R antagonist
AM251 (1 (n=6), 3 (n=6) mg/kg, i.p.) 30 min prior to the reinstatement test (#p<.05
compared to Veh/EFS/COC).

The effects of 1 mg/kg AM251 and vehicle (Veh) and 3 mg/kg
AM251 and vehicle were assessed in different groups of rats, so a
separate 2-way repeated measures (footshock/cocaine x AM251
pretreatment) ANOVA was conducted for each dose. Both doses of
AM251 prevented stress-potentiated reinstatement. For 1 mg/kg
AM251 doses, 2-way repeated measures ANOVA showed an overall
significant effect of reinstatement (Extinction vs. Reinstatement; 1
mg/kg: F(1,5)=26.86, p<0.01), but not drug (Veh vs. AM251;
F(1,5)=5.03, p=0.08) and a significant interaction between the
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reinstatement day and drug (F(1,5)=9.74, p<0.05). Post-hoc testing
showed that reinstatement was observed in Veh-pretreated (p <0.05),
but not AM251 pretreated rats and that reinstatement following vehicle
pretreatment was significantly increased relative to reinstatement
following AM251 (p<0.05). Similarly, for the 3 mg/kg AM251 dose, 2way repeated measures ANOVA revealed significant overall effects of
reinstatement testing (F(1,5)=14.02, p<0.05) and AM251
pretreatment (F(1,5)=12.18, p<0.05) and a significant reinstatement
x pretreatment interaction (F(1,5)=18.24, p<0.01). As with the lower
dose, post-hoc testing demonstrated that reinstatement was observed
in Veh-pretreated rats (p <0.05), but not rats pretreated with 3 mg/kg
AM251 and that reinstatement following vehicle pretreatment was
significantly increased relative to reinstatement following 3 mg/kg
AM251 (p<0.05).

Experiment 2: Effect of CB1R antagonism on
cocaine-primed and stress-triggered
reinstatement of cocaine seeking
In contrast to stress-potentiated cocaine-induced reinstatement,
AM251 did not prevent reinstatement in response to a 10 mg/kg i.p.
priming dose of cocaine (Fig. 2A). Effects of pretreatment with 1
mg/kg and 3 mg/kg AM251 on cocaine-primed reinstatement were
tested in separate groups of rats. In both cases 2-way repeated
measures reinstatement (reinstatement vs. extinction) x drug
pretreatment (AM251 vs. Veh) ANOVA revealed overall reinstatement
effects (F(1,7)=18.62, p<0.001 and F(1,7)=25.51, p<0.01) but not
overall effects of AM251 and no reinstatement x AM251 pretreatment
interactions.
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Figure 2. Cocaine-primed or stress-induced reinstatement is not CB1R-dependent.
Data represent mean active lever responses (± SEM) during 2-h extinction and
reinstatement tests. A. Cocaine-primed reinstatement is observed when rats are given
a systemic injection of a high dose of cocaine (COC, 10 mg/kg, i.p.; **p<.01
compared to extinction). Cocaine-primed reinstatement is not significantly attenuated
by pre-treatment with the CB1R antagonist, AM251 (1 (n=8), 3 (n=8) mg/kg, i.p.) 30
min prior to the cocaine injection. B. Stress-induced reinstatement is observed when
rats are given electric footshock stress (EFS) for 15 min immediately followed by the
reinstatement session in rats with a history of long-access self-administration
(**p<.01 compared to extinction). Stress-induced reinstatement is not significantly
attenuated by pretreatment with AM251 (1 mg/kg, i.p.; n=5) 30 min prior to EFS.

While stress-potentiated reinstatement in short-access rats was
blocked by pretreatment with AM251 (1 mg/kg, ip), stress-triggered
reinstatement in long-access rats was unaffected by the same
treatment (Fig 2B). A 2-way repeated measures drug pretreatment
(Veh vs AM251) x reinstatement (no footshock vs footshock) ANOVA
revealed overall reinstatement effects (F(1,4)=37.16, p<0.01) but no
overall effects of AM251 and no reinstatement x AM251 pretreatment
interactions. Post-hoc testing demonstrated that reinstatement was
observed in both Veh- (p <0.01), and AM251-pretreated rats (p<0.01)
but that reinstatement following vehicle pretreatment was not
significantly different from reinstatement following 1 mg/kg AM251
(p>0.05).
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Experiment 3: Effect of CB1R antagonism on
responding for food and basal locomotor activity
AM251 at a dose of 3 mg/kg produced dose-dependent
reductions in food-reinforced lever pressing while 1 mg/kg AM251 was
without significant effect (Fig. 3). A one-way repeated measures
ANOVA revealed a significant AM251 effect on food-reinforced
responding (Veh, 1 mg/kg AM251, 3 mg/kg AM251; F(2,12)=4.41,
p<0.05) and post hoc testing demonstrated that pretreatment with 3
mg/kg, but not 1 mg/kg AM251 significantly attenuated foodreinforced lever responding compared to vehicle pretreatment
(p<0.05).

Figure 3. Food-reinforced lever pressing is attenuated by pre-treatment with the
CB1R antagonist AM251. Data are presented as mean food lever responses during the
30-min session ± SEM. Pre-treatment with AM251 30 min prior to the beginning of the
session significantly attenuated food-reinforced lever pressing at the higher dose (3
mg/kg, i.p), but not the low dose (1 mg/kg, i.p.; n=7; *p<.05 compared to Veh).
Each rat received each drug treatment and the order of drug treatment was
counterbalanced.
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AM251 effects on basal locomotor activity were tested (Table 2).
A one-way repeated measures ANOVA did not reveal a significant
effect of the drug (Veh, 1 mg/kg AM251, 3 mg/kg AM251) for either
total activity (F(2,10)=2.56, p=0.13) or ambulatory movement
(F(2,10)=0.81, p=0.47) consistent with previous findings (Adamczyk et
al. 2012).
Table 2. Effects of CB1R antagonism on locomotor activity
1st 30 min

2nd 30 min

Total 1 hr

Total

Ambulatory Total

Vehicle

1632 ±
286

701 ± 122

611 ± 138 301 ± 64

Ambulatory Total
2244 ±
249

Ambulatory
1003 ± 122

AM251
(1)

1539 ±
280

681 ± 104

854 ± 231 323 ± 75

2393 ±
435

1005 ± 149

AM251
2058 ±
776 ± 114
1391 ±
484 ± 70
3450 ±
1261 ± 163
(3)
283
257
477
Data represented are mean activity counts ± SEM for total (total beam breaks) and
ambulatory (consecutive beam breaks) activity. The data are presented as activity
during the 1st 30 min, 2nd 30 min, and total 1-h after the injection of either Vehicle
(1:1:18 ethanol: Cremaphor: saline) or AM251 (1, 3 mg/kg, i.p.). Systemic
administration of AM251 did not significantly affect total or ambulatory activity (n=6)
during the 1-h after the injection.

Experiment 4: Effect of footshock stress on
endocannabinoid content in the medial prefrontal
cortex
The effects of footshock stress on contents of AEA and 2-AG in
subregions of the medial prefrontal cortex were examined in drugnaïve rats euthanized 15 min after the footshock period ended (Table
3). A 2-way ANOVA with footshock and brain region as factors
revealed an overall significant effect of footshock on AEA content
(F(1,36)=8.411 p<.01) and an overall effect of brain region (F(1,36) =
18.10, p<.001) on 2-AG content. We also ran planned comparisons in
each region for the effect of stress on AEA or 2-AG in each region.
Despite trends in each region AEA was not significantly increased in
any brain region (PL: p=0.10; IL: p=0.12; AC: p=0.20) but 2-AG
content was significantly increased in the AC as a result of stress
(p<.05).
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Table 3. Effects of footshock stress on endocannabinoid content in
subregions of the medial prefrontal cortex
2-AG (nmol/g tissue)
Anterior Cingulate
Prelimbic

AEA (pmol/g tissue)

Control

Shock

Control

Shock

2.4 ± 0.6

5.6 ± 0.5

8.9 ± 0.9

19.3 ± 5.1

11.0 ± 1.8

9.6 ± 1.5

7.1 ± 2.7

17.8 ± 5.4

Infralimbic
4.6 ± 0.7
5.5 ± 0.8
6.3 ± 1.0
16.8 ± 7.1
Data represented are mean concentrations of the endocannabinoids 2arachidonylglycerol (2-AG; nmol/g tissue) and anandamide (AEA; pmol/g tissue) 15
min after termination of a 15 min-footshock (n=7) or in control rats (n=7). There was
a significant effect of footshock stress on AEA levels across the 3 brain regions
(p<.001). Footshock stress significantly increased 2-AG in the anterior cingulate
cortex (p<.05) and levels of 2-AG in the prelimbic cortex are significantly higher than
those in the anterior cingulate or infralimbic (p<.001).

Discussion
Under conditions where it does not directly trigger relapse,
stress can promote responsiveness to other stimuli, thereby “setting
the stage” for drug use. We have previously modeled this stagesetting effect using a self-administration/approach in which footshock
stress augments cocaine-induced reinstatement in rats (Graf et al.
2013). We reproduced these findings in the present study,
demonstrating that, under the self–administration parameters used
(0.5 mg/kg/inf; 14 × 2 hrs/day), footshock alone does not reinstate
cocaine seeking, but potentiates reinstatement in response to an
injection of an otherwise subthreshold dose of cocaine (2.5 mg/kg,
i.p.). We demonstrate that this stage-setting effect of stress is
dependent on CB1R signaling. In our paradigm, systemic
administration of the CB1R antagonist, AM251, prevents stresspotentiated reinstatement but does not affect reinstatement in
response to a priming dose of cocaine (10 mg/kg, ip) or alter
reinstatement triggered by shock alone in rats with a history of
cocaine self-administration under long-access (daily 6-h/day)
conditions. Moreover, although AM251 also attenuated food-reinforced
lever pressing, reductions in reinstatement were observed at an
AM251 dose that did not alter food-reinforced responding, while
reductions in locomotor activity were not observed at any dose tested.
Endocannabinoid signaling in the brain is stress-responsive and
is necessary for stress adaptation and coping (Hill et al. 2011;
McLaughlin et al. 2012; McLaughlin et al. 2013; McLaughlin et al.
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2014). There are two subtypes of cannabinoid receptors: CB1 and
CB2. The CB1 receptor is considered to be the predominant
cannabinoid receptor in the brain and is expressed in regions critical
for motivated behavior, including the prefrontal cortex, nucleus
accumbens, and the ventral tegmental area (Devane et al. 1988;
Egertova et al. 1998; Herkenham et al. 1991; Melis et al. 2004; Pettit
et al. 1998; Wenger et al. 2003), thus positioning CB1Rs as regulators
of behavioral processes that enable organisms to effectively respond to
stressors and as potential mediators through which stress can
influence drug-seeking behavior. Our finding that AM251 prevented
the potentiating effects of stress on cocaine-induced reinstatement is
consistent with this role for CB1Rs. Moreover, the finding that AM251
did not alter either cocaine-primed or stress-triggered reinstatement in
this model suggests that while CB1Rs are important for the interaction
between stress and cocaine, they may be less important for the
response to either stimuli by itself.
Our study is not the first to examine the contribution of CB1Rs
to the reinstatement of extinguished cocaine seeking. De Vries et al.
(2001) reported that the CB1R agonist, HU210, reinstated cocaine
seeking, while the CB1R antagonist, rimonabant, attenuated cocaineprimed and cue-induced reinstatement but not stress-triggered
reinstatement in male Wistar and Long Evans rats. These effects on
cocaine-primed reinstatement were reproduced by Xi et al. (2006) and
Adamcyzk et al. (2012) using AM251. It is possible that experimental
differences, such as rat strains employed (our study is the only one
using Sprague Dawley rats), route of administration for the cocaineprime injection, self-administration parameters, or CB1R antagonist
pretreatment times and doses underlie the different responses
obtained. However, we are not the first to report as others have also
reported a lack of effect of CB1R antagonism on cocaine-primed
reinstatement. Another study did report attenuation of cocaine-primed
reinstatement by AM251 (Filip et al. 2006), but the AM251 dose at
which effects were observed in that study (10 mg/kg, ip) was very
high and effects within the AM251 dose range used in the present
study were not found. Moreover, Kupferschmidt et al. (2012) found
that icv administration of AM251 blocked CRF-induced reinstatement
but failed to block footshock- or cocaine-primed reinstatement. In
addition, studies using mice have found no effect of CB1R antagonism
on cocaine-primed reinstatement following cocaine self-administration
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(Ward et al. 2009) or cocaine-conditioned place preference (Vaughn et
al. 2011). Clarification of the precise conditions under which CB1Rs do
and do not contribute to cocaine-primed reinstatement will require
further investigation. Notably, CB1R antagonists or negative allosteric
modulators have also been reported to inhibit on drug-primed heroin
(De Vries et al. 2003; Fattore et al. 2005) and methamphetamine
(Jing et al. 2014) reinstatement as well cue-induced reinstatement
following alcohol (de Bruin et al. 2011), heroin (De Vries et al. 2003),
methamphetamine (Jing et al. 2014) and nicotine (De Vries et al.
2005) self-administration. In contrast to our findings, these results
suggest that the involvement of CB1Rs in drug seeking may extend
beyond the potentiating effects of stress.
Our finding that AM251 fails to block stress-triggered
reinstatement is consistent with studies by De Vries et al. (2001) and
Kupferschmidt et al. (2012). We previously reported that the
mechanisms responsible for stress-triggered reinstatement and those
that mediate stress-potentiated reinstatement are distinct. For
example, eliminating the corticosterone response to stress has no
effect on stress-triggered reinstatement of extinguished cocaine
seeking (Erb et al. 1998; Graf et al. 2011), but prevents the ability of
stress to potentiate low-dose cocaine-induced reinstatement (Graf et
al. 2013). Similar to corticosterone, we observe that the CB1R
antagonist AM251 blocked stress-potentiated reinstatement, but not
cocaine-primed or stress-triggered reinstatement, suggesting that
endocannabinoid involvement in cocaine-seeking behavior in these
conditions is also more important for the interaction between stress
and cocaine than either stimuli alone. This parallel between
corticosterone and endocannabinoids is interesting, considering that
corticosterone has been reported to regulate endocannabinoid
contents in brain regions that have been implicated in cocaine-seeking
behavior (Hill et al. 2011; Kalivas and McFarland 2003; McFarland et
al. 2004; Rademacher et al. 2008). For example, restraint stress
produces glucocorticoid-dependent increases in the endocannabinoid,
2-AG, in the prelimbic cortex, resulting in a CB1R-dependent
attenuation of GABAergic neurotransmission that disinhibits pyramidal
neuron outputs (Hill et al. 2011) that likely include a key glutamatergic
pathway to the nucleus accumbens core that has been implicated in
cocaine-seeking behavior (McFarland et al. 2004).
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In the present study, we observed that footshock stress
increased AEA contents in PL, IL and AC subregions of the medial
prefrontal cortex and increased 2-AG content in the AC. These results
are consistent with prior studies indicating that the prefrontal cortical
endocannabinoid system is modulated by stress and anxiety conditions
(Hill et al. 2011; McLaughlin et al. 2012; Morena et al. 2014;
Rademacher et al. 2008; Roberts et al. 2012). However, prefrontal
cortical responses vary in response to different stressors, whereby AEA
is decreased following acute restraint (Hill et al. 2011) and swim stress
(McLaughlin et al. 2012), or chronic restraint stress (Rademacher et al.
2008), but is increased following a single footshock (Morena et al.
2014), and 2-AG is increased after acute (Hill et al. 2011) or chronic
restraint stress (Rademacher et al. 2008). While most stressors result
in decreased AEA, footshock stress appears unique in eliciting
increases in AEA in periaqueductal grey (Hohmann et al. 2005),
basolateral amygdala, and dorsal hippocampus (Morena et al. 2014).
While it is not presently clear why footshock stress produces unique
AEA responses, it is possible that that this increase is observed in part
as a consequence of pain mechanisms. These data support a role for
footshock stress-induced increases in endocannabinoid content in
relevant brain regions though these levels were not examined in rats
with a history of cocaine self-administration or under reinstating
conditions.
Several pieces of evidence indicate that the effects of AM251 to
reduce stress-potentiated reinstatement are not the result of nonspecific motor effects. However to fully examine that possibility, we
initially assessed the effects of AM251 on food-reinforced lever
pressing. AM251 dose-dependently suppressed food-reinforced
responding. However, while the higher AM251 dose tested (3 mg/kg)
reduced both reinstatement and food-reinforced responding, the lower
AM251 dose (1 mg/kg) selectively attenuated stress-potentiated
reinstatement. These findings are consistent with prior reports showing
significantly lower food-reinforced responding when pre-treated with 3
mg/kg but not 1 mg/kg (Adamczyk et al. 2012). Notably, there is
strong evidence for endocannabinoid involvement in feeding,
metabolism and obesity (Bellocchio et al. 2006; Kirkham and Tucci
2006; Silvestri and Di Marzo 2013), suggesting that the attenuation of
food-reinforced responding represents an effect on appetite, and not a
motor effect. Consistent with this possibility, AM251 did not attenuate
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cocaine-primed or shock-triggered reinstatement. In order to further
assess any potential non-specific motor effects of AM251, we also
tested rats for effects of AM251 on locomotor activity. Pre-treatment
with AM251 had no significant effect on locomotor activity at either
dose, which is also consistent with earlier reports (Adamczyk et al.
2012), suggesting that AM251 effects on reinstatement behavior were
not the result of non-specific motor suppression. In fact, there was a
trend towards increased locomotor activity at the higher AM251 dose.
Taken altogether, our findings suggest that endocannabinoid
involvement in stress-potentiated reinstatement is specific to the
ability of stress to potentiate the responsiveness to subthreshold
reinstating stimuli.
The present findings add to a large body of research implicating
endocannabinoid signaling in cocaine addiction (see Wiskerke et al.
2008 for review). Notably, polymorphisms of the gene for the CB1
receptor, CNR1, are associated with cocaine dependence (Clarke et al.
2013; Lopez-Moreno et al. 2012; Zuo et al. 2007; Zuo et al. 2009)
and it has been suggested that circulating endocannabinoids may be a
viable biomarker for cocaine use disorder in humans (Pavon et al.
2013). Demonstration of a contribution of endocannabinoid signaling
to cocaine use in the context of stress may shed additional light on the
complex relationship between endocannabinoids and cocaine addiction.
While issues related to psychiatric side effects may limit the clinical
utility of CB1R antagonists (Christensen et al. 2007), at minimum
these data provide mechanistic insight into the processes through
which stress influences drug relapse and therefore may guide future
treatment approaches.

Acknowledgments
This research was funded by NIH grant DA015758 to JR Mantsch; NIH grant
DA038663 to JR Mantsch and CJ Hillard and by the Research and Education
Component of the Advancing a Healthier Wisconsin Endowment at the Medical
College of Wisconsin.

Footnotes
The authors declare no conflicts of interest.

Psychopharmacology, Vol 233, No. 1 (January 2016): pg. 99-109. DOI. This article is © Springer-Verlag Berlin Heidelberg
and permission has been granted for this version to appear in e-Publications@Marquette. Springer-Verlag Berlin
Heidelberg does not grant permission for this article to be further copied/distributed or hosted elsewhere without the
express permission from Springer-Verlag Berlin Heidelberg.

22

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

References
Adamczyk P, Miszkiel J, McCreary AC, Filip M, Papp M, Przegalinski E. The
effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor
antagonists on cocaine addictive behavior in rats. Brain Res.
2012;1444:45–54.
Bellocchio L, Mancini G, Vicennati V, Pasquali R, Pagotto U. Cannabinoid
receptors as therapeutic targets for obesity and metabolic diseases.
Curr Opin Pharmacol. 2006;6:586–91.
Blacktop JM, Seubert C, Baker DA, Ferda N, Lee G, Graf EN, Mantsch JR.
Augmented cocaine seeking in response to stress or CRF delivered into
the ventral tegmental area following long-access self-administration is
mediated by CRF receptor type 1 but not CRF receptor type 2. J
Neurosci. 2011;31(31):11396–403.
Brusco A, Tagliaferro PA, Saez T, Onaivi ES. Ultrastructural localization of
neuronal brain CB2 cannabinoid receptors. Ann N Y Acad Sci.
2008;1139:450–7.
Buffalari DM, See RE. Footshock stress potentiates cue-induced cocaineseeking in an animal model of relapse. Physiol Behav. 2009;98:614–7.
Capriles N, Rodaros D, Sorge RE, Stewart J. A role for the prefrontal cortex in
stress- and cocaine-induced reinstatement of cocaine seeking in rats.
Psychopharmacology (Berl) 2003;168:66–74.
Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A. Efficacy and
safety of the weight-loss drug rimonabant: a meta-analysis of
randomised trials. Lancet. 2007;370:1706–13.
Clarke TK, Bloch PJ, Ambrose-Lanci LM, Ferraro TN, Berrettini WH, Kampman
KM, Dackis CA, Pettinati HM, O’Brien CP, Oslin DW, Lohoff FW. Further
evidence for association of polymorphisms in the CNR1 gene with
cocaine addiction: confirmation in an independent sample and metaanalysis. Addict Biol. 2013;18:702–8.
Coffey SF, Saladin ME, Drobes DJ, Brady KT, Dansky BS, Kilpatrick DG.
Trauma and substance cue reactivity in individuals with comorbid
posttraumatic stress disorder and cocaine or alcohol dependence. Drug
Alcohol Depend. 2002;65:115–27.
de Bruin NM, Lange JH, Kruse CG, Herremans AH, Schoffelmeer AN, van
Drimmelen M, De Vries TJ. SLV330, a cannabinoid CB(1) receptor
antagonist, attenuates ethanol and nicotine seeking and improves
inhibitory response control in rats. Behav Brain Res. 2011;217:408–
15.
De La Garza R, 2nd, Ashbrook LH, Evans SE, Jacobsen CA, Kalechstein AD,
Newton TF. Influence of verbal recall of a recent stress experience on
anxiety and desire for cocaine in non-treatment seeking, cocaineaddicted volunteers. Am J Addict. 2009;18:481–7.
Psychopharmacology, Vol 233, No. 1 (January 2016): pg. 99-109. DOI. This article is © Springer-Verlag Berlin Heidelberg
and permission has been granted for this version to appear in e-Publications@Marquette. Springer-Verlag Berlin
Heidelberg does not grant permission for this article to be further copied/distributed or hosted elsewhere without the
express permission from Springer-Verlag Berlin Heidelberg.

23

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

De Vries TJ, de Vries W, Janssen MC, Schoffelmeer AN. Suppression of
conditioned nicotine and sucrose seeking by the cannabinoid-1
receptor antagonist SR141716A. Behav Brain Res. 2005;161:164–8.
De Vries TJ, Homberg JR, Binnekade R, Raaso H, Schoffelmeer AN.
Cannabinoid modulation of the reinforcing and motivational properties
of heroin and heroin-associated cues in rats. Psychopharmacology
(Berl) 2003;168:164–9.
De Vries TJ, Shaham Y, Homberg JR, Crombag H, Schuurman K, Dieben J,
Vanderschuren LJ, Schoffelmeer AN. A cannabinoid mechanism in
relapse to cocaine seeking. Nat Med. 2001;7:1151–4.
Devane WA, Dysarz FA, 3rd, Johnson MR, Melvin LS, Howlett AC.
Determination and characterization of a cannabinoid receptor in rat
brain. Mol Pharmacol. 1988;34:605–13.
Duncan E, Boshoven W, Harenski K, Fiallos A, Tracy H, Jovanovic T, Hu X,
Drexler K, Kilts C. An fMRI study of the interaction of stress and
cocaine cues on cocaine craving in cocaine-dependent men. Am J
Addict. 2007;16:174–82.
Egertova M, Giang DK, Cravatt BF, Elphick MR. A new perspective on
cannabinoid signalling: complementary localization of fatty acid amide
hydrolase and the CB1 receptor in rat brain. Proc Biol Sci.
1998;265:2081–5.
Erb S, Shaham Y, Stewart J. The role of corticotropin-releasing factor and
corticosterone in stress- and cocaine-induced relapse to cocaine
seeking in rats. J Neurosci. 1998;18(14):5529–36.
Fattore L, Spano S, Cossu G, Deiana S, Fadda P, Fratta W. Cannabinoid CB(1)
antagonist SR 141716A attenuates reinstatement of heroin selfadministration in heroin-abstinent rats. Neuropharmacology.
2005;48:1097–1104.
Feltenstein MW, See RE. Potentiation of cue-induced reinstatement of
cocaine-seeking in rats by the anxiogenic drug yohimbine. Behav Brain
Res. 2006;174:1–8.
Furnari M, Epstein DH, Phillips KA, Jobes ML, Kowalczyk WJ, Vahabzadeh M,
Lin JL, Preston KL. Some of the people, some of the time: field
evidence for associations and dissociations between stress and drug
use. Psychopharmacology (Berl) 2015
Graf EN, Hoks MA, Baumgardner J, Sierra J, Vranjkovic O, Bohr C, Baker DA,
Mantsch JR. Adrenal activity during repeated long-access cocaine selfadministration is required for later CRF-Induced and CRF-dependent
stressor-induced reinstatement in rats. Neuropsychopharmacology.
2011;36:1444–54.
Graf EN, Wheeler RA, Baker DA, Ebben AL, Hill JE, McReynolds JR, Robble MA,
Vranjkovic O, Wheeler DS, Mantsch JR, Gasser PJ. Corticosterone acts
in the nucleus accumbens to enhance dopamine signaling and
Psychopharmacology, Vol 233, No. 1 (January 2016): pg. 99-109. DOI. This article is © Springer-Verlag Berlin Heidelberg
and permission has been granted for this version to appear in e-Publications@Marquette. Springer-Verlag Berlin
Heidelberg does not grant permission for this article to be further copied/distributed or hosted elsewhere without the
express permission from Springer-Verlag Berlin Heidelberg.

24

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

potentiate reinstatement of cocaine seeking. J Neurosci.
2013;33:11800–10.
Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC.
Characterization and localization of cannabinoid receptors in rat brain:
a quantitative in vitro autoradiographic study. J Neurosci.
1991;11:563–83.
Hill MN, McLaughlin RJ, Pan B, Fitzgerald ML, Roberts CJ, Lee TT, Karatsoreos
IN, Mackie K, Viau V, Pickel VM, McEwen BS, Liu QS, Gorzalka BB,
Hillard CJ. Recruitment of prefrontal cortical endocannabinoid signaling
by glucocorticoids contributes to termination of the stress response. J
Neurosci. 2011;31:10506–15.
Hill MN, Patel S, Campolongo P, Tasker JG, Wotjak CT, Bains JS. Functional
interactions between stress and the endocannabinoid system: from
synaptic signaling to behavioral output. J Neurosci. 2010;30:14980–6.
Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R, Krey
JF, Walker JM, Holmes PV, Crystal JD, Duranti A, Tontini A, Mor M,
Tarzia G, Piomelli D. An endocannabinoid mechanism for stressinduced analgesia. Nature. 2005;435:1108–1112.
Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC,
Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG.
International Union of Pharmacology. XXVII. Classification of
cannabinoid receptors. Pharmacological reviews. 2002;54:161–202.
Jing L, Qiu Y, Zhang Y, Li JX. Effects of the cannabinoid CB(1) receptor
allosteric modulator ORG 27569 on reinstatement of cocaine- and
methamphetamine-seeking behavior in rats. Drug Alcohol Depend.
2014;143:251–6.
Kalivas PW, McFarland K. Brain circuitry and the reinstatement of cocaineseeking behavior. Psychopharmacology (Berl) 2003;168:44–56.
Kirkham TC, Tucci SA. Endocannabinoids in appetite control and the
treatment of obesity. CNS Neurol Disord Drug Targets. 2006;5:272–
92.
Kupferschmidt DA, Klas PG, Erb S. Cannabinoid CB1 receptors mediate the
effects of corticotropin-releasing factor on the reinstatement of cocaine
seeking and expression of cocaine-induced behavioural sensitization.
Br J Pharmacol. 2012;167:196–206.
Lopez-Moreno JA, Echeverry-Alzate V, Buhler KM. The genetic basis of the
endocannabinoid system and drug addiction in humans. J
Psychopharmacol. 2012;26:133–43.
Mantsch JR, Baker DA, Francis DM, Katz ES, Hoks MA, Serge JP. Stressor- and
corticotropin releasing factor-induced reinstatement and active stressrelated behavioral responses are augmented following long-access
cocaine self-administration by rats. Psychopharmacology (Berl)
2008a;195:591–603.
Psychopharmacology, Vol 233, No. 1 (January 2016): pg. 99-109. DOI. This article is © Springer-Verlag Berlin Heidelberg
and permission has been granted for this version to appear in e-Publications@Marquette. Springer-Verlag Berlin
Heidelberg does not grant permission for this article to be further copied/distributed or hosted elsewhere without the
express permission from Springer-Verlag Berlin Heidelberg.

25

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Mantsch JR, Baker DA, Serge JP, Hoks MA, Francis DM, Katz ES. Surgical
adrenalectomy with diurnal corticosterone replacement slows
escalation and prevents the augmentation of cocaine-induced
reinstatement in rats self-administering cocaine under long-access
conditions. Neuropsychopharmacology. 2008b;33:814–26.
Mantsch JR, Goeders NE. Ketoconazole does not block cocaine discrimination
or the cocaine-induced reinstatement of cocaine-seeking behavior.
Pharmacol Biochem Behav. 1999;64:65–73.
Mantsch JR, Yuferov V, Mathieu-Kia AM, Ho A, Kreek MJ. Effects of extended
access to high versus low cocaine doses on self-administration,
cocaine-induced reinstatement and brain mRNA levels in rats.
Psychopharmacology (Berl) 2004;175:26–36.
McFarland K, Davidge SB, Lapish CC, Kalivas PW. Limbic and motor circuitry
underlying footshock-induced reinstatement of cocaine-seeking
behavior. J Neurosci. 2004;24:1551–60.
McLaughlin RJ, Hill MN, Bambico FR, Stuhr KL, Gobbi G, Hillard CJ, Gorzalka
BB. Prefrontal cortical anandamide signaling coordinates coping
responses to stress through a serotonergic pathway. Eur
Neuropsychopharmacol. 2012;22:664–71.
McLaughlin RJ, Hill MN, Dang SS, Wainwright SR, Galea LA, Hillard CJ,
Gorzalka BB. Upregulation of CB(1) receptor binding in the
ventromedial prefrontal cortex promotes proactive stress-coping
strategies following chronic stress exposure. Behav Brain Res.
2013;237:333–7.
McLaughlin RJ, Hill MN, Gorzalka BB. A critical role for prefrontocortical
endocannabinoid signaling in the regulation of stress and emotional
behavior. Neurosci Biobehav Rev. 2014;42C:116–131.
McReynolds JR, Pena DF, Blacktop JM, Mantsch JR. Neurobiological
mechanisms underlying relapse to cocaine use: contributions of CRF
and noradrenergic systems and regulation by glucocorticoids. Stress.
2014;17:22–38.
Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL. Endocannabinoids
mediate presynaptic inhibition of glutamatergic transmission in rat
ventral tegmental area dopamine neurons through activation of CB1
receptors. J Neurosci. 2004;24:53–62.
Morena M, Roozendaal B, Trezza V, Ratano P, Peloso A, Hauer D, Atsak P,
Trabace L, Cuomo V, McGaugh JL, Schelling G, Campolongo P.
Endogenous cannabinoid release within prefrontal-limbic pathways
affects memory consolidation of emotional training. Proc Natl Acad Sci
USA. 2014;111(51):18333–8.
Onaivi ES. Commentary: Functional Neuronal CB2 Cannabinoid Receptors in
the CNS. Curr Neuropharmacol. 2011;9:205–8.

Psychopharmacology, Vol 233, No. 1 (January 2016): pg. 99-109. DOI. This article is © Springer-Verlag Berlin Heidelberg
and permission has been granted for this version to appear in e-Publications@Marquette. Springer-Verlag Berlin
Heidelberg does not grant permission for this article to be further copied/distributed or hosted elsewhere without the
express permission from Springer-Verlag Berlin Heidelberg.

26

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, Myers L, Mora
Z, Tagliaferro P, Gardner E, Brusco A, Akinshola BE, Liu QR, Hope B,
Iwasaki S, Arinami T, Teasenfitz L, Uhl GR. Discovery of the presence
and functional expression of cannabinoid CB2 receptors in brain. Ann N
Y Acad Sci. 2006;1074:514–36.
Patel S, Rademacher DJ, Hillard CJ. Differential regulation of the
endocannabinoids anandamide and 2-arachidonoylglycerol in the limbic
forebrain by dopamine receptor activity. J Pharmacol Exp Ther.
2003;306(3):880–8.
Pavon FJ, Araos P, Pastor A, Calado M, Pedraz M, Campos-Cloute R, Ruiz JJ,
Serrano A, Blanco E, Rivera P, Suarez J, Romero-Cuevas M, Pujadas M,
Vergara-Moragues E, Gornemann I, Torrens M, de la Torre R,
Rodriguez de Fonseca F. Evaluation of plasma-free endocannabinoids
and their congeners in abstinent cocaine addicts seeking outpatient
treatment: impact of psychiatric co-morbidity. Addict Biol.
2013;18:955–69.
Pertwee RG. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol
Ther. 1997;74:129–80.
Pertwee RG, Ross RA. Cannabinoid receptors and their ligands. Prostaglandins
Leukot Essent Fatty Acids. 2002;66:101–21.
Peters J, LaLumiere RT, Kalivas PW. Infralimbic prefrontal cortex is
responsible for inhibiting cocaine seeking in extinguished rats. J
Neurosci. 2008;28:6046–53.
Pettit DA, Harrison MP, Olson JM, Spencer RF, Cabral GA.
Immunohistochemical localization of the neural cannabinoid receptor in
rat brain. J Neurosci Res. 1998;51:391–402.
Preston KL, Epstein DH. Stress in the daily lives of cocaine and heroin users:
relationship to mood, craving, relapse triggers, and cocaine use.
Psychopharmacology (Berl) 2011;218:29–37.
Rademacher DJ, Meier SE, Shi L, Ho WS, Jarrahian A, Hillard CJ. Effects of
acute and repeated restraint stress on endocannabinoid content in the
amygdala, ventral striatum, and medial prefrontal cortex in mice.
Neuropharmacology. 2008;54:108–16.
Roberts CJ, Stuhr KL, Hillard CJ. Swim stress differentially affects limbic
contents of 2-arachidonoylglycerol and 2-oleoylglycerol. Neuroscience.
2012;204:74–82.
Shaham Y, Erb S, Stewart J. Stress-induced relapse to heroin and cocaine
seeking in rats: a review. Brain Res Brain Res Rev. 2000;33:13–33.
Sidhpura N, Parsons LH. Endocannabinoid-mediated synaptic plasticity and
addiction-related behavior. Neuropharmacology. 2011;61:1070–87.
Silvestri C, Di Marzo V. The endocannabinoid system in energy homeostasis
and the etiopathology of metabolic disorders. Cell Metab.
2013;17:475–90.
Psychopharmacology, Vol 233, No. 1 (January 2016): pg. 99-109. DOI. This article is © Springer-Verlag Berlin Heidelberg
and permission has been granted for this version to appear in e-Publications@Marquette. Springer-Verlag Berlin
Heidelberg does not grant permission for this article to be further copied/distributed or hosted elsewhere without the
express permission from Springer-Verlag Berlin Heidelberg.

27

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Sinha R. Modeling stress and drug craving in the laboratory: implications for
addiction treatment development. Addict Biol. 2009;14:84–98.
Vaughn LK, Mantsch JR, Vranjkovic O, Stroh G, Lacourt M, Kreutter M, Hillard
CJ. Cannabinoid receptor involvement in stress-induced cocaine
reinstatement: potential interaction with noradrenergic pathways.
Neuroscience. 2012;204:117–24.
Vranjkovic O, Gasser PJ, Gerndt CH, Baker DA, Mantsch JR. Stress-induced
cocaine seeking requires a beta-2 adrenergic receptor-regulated
pathway from the ventral bed nucleus of the stria terminalis that
regulates CRF actions in the ventral tegmental area. J Neurosci.
2014;34(37):12504–14.
Ward SJ, Rosenberg M, Dykstra LA, Walker EA. The CB1 antagonist
rimonabant (SR141716) blocks cue-induced reinstatement of cocaine
seeking and other context and extinction phenomena predicitve of
relapse. Drug Alcohol Depend. 2009;105:248–55.
Wenger T, Moldrich G, Furst S. Neuromorphological background of cannabis
addiction. Brain Res Bull. 2003;61:125–8.
Wiskerke J, Pattij T, Schoffelmeer AN, De Vries TJ. The role of CB1 receptors
in psychostimulant addiction. Addict Biol. 2008;13:225–38.
Xi ZX, Gilbert JG, Peng XQ, Pak AC, Li X, Gardner EL. Cannabinoid CB1
receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role
of glutamate in the nucleus accumbens. J Neurosci. 2006;26:8531–6.
Zuo L, Kranzler HR, Luo X, Covault J, Gelernter J. CNR1 variation modulates
risk for drug and alcohol dependence. Biol Psychiatry. 2007;62:616–
26.
Zuo L, Kranzler HR, Luo X, Yang BZ, Weiss R, Brady K, Poling J, Farrer L,
Gelernter J. Interaction between two independent CNR1 variants
increases risk for cocaine dependence in European Americans: a
replication study in family-based sample and population-based sample.
Neuropsychopharmacology. 2009;34:1504–13.

Corresponding Author: John Mantsch, Department of Biomedical Sciences,
Marquette University, Email: john.mantsch@marquette.edu, Telephone
Number: (414) 288-2036, Fax Number: (414) 288-6564

Psychopharmacology, Vol 233, No. 1 (January 2016): pg. 99-109. DOI. This article is © Springer-Verlag Berlin Heidelberg
and permission has been granted for this version to appear in e-Publications@Marquette. Springer-Verlag Berlin
Heidelberg does not grant permission for this article to be further copied/distributed or hosted elsewhere without the
express permission from Springer-Verlag Berlin Heidelberg.

28

